Clinical Trial Update: A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness of Imiquimod 5% Cream for preventing recurrence of basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Basal Cell Carcinoma | Phase 3 | Status: COMPLETED